RT Journal Article
SR Electronic
T1 Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.11.22271283
DO 10.1101/2022.04.11.22271283
A1 Martínez-Cayuelas, Elena
A1 Blanco-Kelly, Fiona
A1 López-Grondona, Fermina
A1 Tahsin-Swafiri, Saoud
A1 López-Rodríguez, Rosario
A1 Pozo, Rebeca Losada-Del
A1 Mahillo, Ignacio
A1 Moreno, Beatriz
A1 Rodrigo-Moreno, María
A1 Casas-Alba, Dídac
A1 López-González, Aitor
A1 García-Miñaur, Sixto
A1 de los Ángeles Mori, María
A1 Pacio-Mínguez, Marta
A1 Rikeros-Orozco, Emi
A1 Santos-Simarro, Fernando
A1 Cruz-Rojo, Jaime
A1 Quesada-Espinosa, Juan Francisco
A1 Teresa Sánchez-Calvin, María
A1 Pozo, Jaime Sánchez-del
A1 Bernadó-Fonz, Raquel
A1 Isidoro-García, María
A1 Ruiz-Ayucar, Irene
A1 Álvarez, María Isabel
A1 Blanco-Lago, Raquel
A1 De Azua-Brea, Begoña
A1 Eirís, Jesús
A1 García-Peñas, Juan José
A1 Gil- Fournier, Belén
A1 Gómez-Lado, Carmen
A1 Irazabal, Nadia
A1 López, Vanessa
A1 Madrigal, Irene
A1 Málaga, Ignacio
A1 Martínez-Menéndez, Beatriz
A1 Ramiro-Leon, María Soraya
A1 García-Hoyos, María
A1 Prieto-Matos, Pablo
A1 López-Pisón, Javier
A1 Aguilera-Albesa, Sergio
A1 de Andrés, Sara Álvarez
A1 Fernández-Jaén, Alberto
A1 Llano-Rivas, Isabel
A1 Gener, Blanca
A1 Ayuso, Carmen
A1 Arteche-López, Ana
A1 Palomares-Bralo, María
A1 Cueto, Anna
A1 Valenzuela, Irene
A1 Martínez-Monseny, Antonio F.
A1 Lorda-Sánchez, Isabel
A1 Almoguera, Berta
YR 2022
UL http://medrxiv.org/content/early/2022/04/18/2022.04.11.22271283.abstract
AB Background KBG syndrome is a highly variable neurodevelopmental disorder and clinical diagnostic criteria have changed as new patients have been published. Both loss-of-function sequence variants and large deletions (CNVs) involving ANKRD11 have been involved in KBG, but no genotype-phenotype correlation has been reported to date. This study presents the clinical and molecular characteristics of 67 new patients with KBG syndrome and the results of the first genotype-phenotype correlation leveraging data on 273 patients previously published.Methods 67 patients with KBG syndrome were recruited through a Spanish collaborative effort and were assessed using a custom phenotypic questionnaire. The frequency of all features was calculated. Manifestations present in >50% of the patients and a “severity score” were used to perform a genotype-phenotype correlation in the 340 KBG patients.Results Neurodevelopmental delay (95%), comorbidites (82.8%), macrodontia (80.9%), triangular face (71%), characteristic ears (76%), nose (75.9%) and eyebrows (67.3%) were the most prevalent features in the 67 patients. The genotype-phenotype correlation yielded significant associations with the triangular face (71.1% in patients with sequence variants vs 45.2% in CNVs, p=0.015), short stature (62.5% variants in exon 9 vs. 27.8% outside; p=0.009) and macrodontia (with larger deletions, p=0.028), ID/ADHD/ASD (70.4% in c.1903_1907del vs. 89.4%; p=0.012) and a higher phenotypic score in patients with sequence variants compared with CNVs (p=0.005).Conclusions We present a detailed phenotypic description of KBG syndrome in the largest series of patients reported to date, provide evidence of a genotype-phenotype correlation between some KBG features and specific ANKRD11 aberrations, and propose updated clinical diagnostic criteria based on our findings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a Juan Rodes program (JR17/00020), a grant from Fondo de Investigaciones Sanitarias (FIS, PI18/01098), funded by Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Fundacion Jimenez Diaz University Hospital gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript